Videre til indhold


Lif – The Danish Association of the Pharmaceutical Industry

Lif works to ensure that the pharmaceutical industry has the best possible conditions to develop, market, distribute and provide information on medicinal products.

 

About Lif

Lif’s 39 members include Danish as well as foreign companies. Lif works within all the links in the companies’ value chain: Ensuring better conditions for research and innovation, formulation of rules and legislation on regulatory conditions, productivity conditions and improved market access. 

Lif works to ensure that the pharmaceutical industry has the best possible conditions to develop, market, distribute and provide information on medicinal products.

Innovation for healthier lives and a more sustainable society

Lif has a vision of a healthier Denmark with fast and easy access for all to the best preventive health measures and medicines, a society that fosters growth, prosperity and sustainability.

We strive to ensure that companies involved in developing and producing new and innovative medicines enjoy the best possible framework conditions and that the industry is seen as socially responsible and as adding value to society.


Articles of Association (2024)

Read the Articles of Association for The Danish Association of the Pharmaceutical Industry – Lif.

Board of Directors and Management

Lif’s Board of Directors manages the Association and consists of 10 board members.

Get in touch

Find contact information of employees in Lif’s secretariat.


Collaboration with the regions
Rules and codes
About ENLI

Our vision

The value of pharmaceuticals for the Danish society should be visible and recognised in patient-centric health service. The pharmaceutical industry should be regarded as a responsble partner that makes a valuable contribution to the community.

Our mission

Lif’s mission is to work to ensure that the pharmaceutical industry has the best possible conditions to research, develop, market, distribute and provide information on medicinal products so as to ensure that patients have extensive, fast access and rapid access to the best medical treatment.

Our values

The value of pharmaceuticals for the Danish society should be visible and recognised in patient-centric health service. The pharmaceutical industry should be regarded as a responsble partner that makes a valuable contribution to the community.

A Sound Business: The foundation for the industry’s existence is a sound financial and commercial basis. Results generate earnings, growth, higher employment, more exports – and hence the prerequisites for the development of new medicines.

Research and Development: Research is core to the pharmaceutical industry – the ability to constantly improve existing medicines and develop new therapies that benefit the treatment of patients.

Responsibility: Through responsible collaboration with third parties Lif creates sound frameworks for the continuing education of doctors, research into new and improved therapies, information about medicines and medicine prices in Denmark.

Partnership for Health: Lif is committed to entering into partnerships for health that will ensure patients of the best possible treatments.


Contact Lif

Henrik VestergaardDeputy Director+45 39 27 60 60hv@lif.dk
Solveig Chræmmer Head of Secretariat+ 45 39 15 09 83sri@lif.dk

Our members

Lif has 39 Danish and international member companies. Get an overview of who they are and read more about each company by clicking on the logo.

Abbvie
Alk
Almirall Nordic
Amgen
Astellas
AstraZeneca
Bayer
BioArctic
Biogen
Boehringer Ingelheim
Bristol Myers Squibb
Chiesi
Daiichi-Sankyo
Eisai
Ferring
Fertin
Fuji Diosynth Biotechnologies
Galderma
Gilead
Grünethal
GSK
IBSA
Incyte Biosciences Denmark ApS
Johnson & Johnson
Leo
Lilly
Lundbeck
Merck
MSD
Novartis
Novo Nordisk
Otsuka
Pfizer
Roche
Sanofi
SmartPractice
Takeda
UCB
Vertex